Michael Mina, MD, PhD, explains Invivyd's accelerated approval path for VYD2311 and how it could change the timing of COVID-19 protection. Invivyd plans to seek accelerated approval for VYD2311 based ...
FORT WAYNE, Ind.--(BUSINESS WIRE)--Enterprise Health, an occupational and employee health IT solution provider, today launched Channel 19, a stand-alone application to help employers and hospital ...
Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval The most common solicited local adverse event for ...
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
We’re sorry, we are currently experiencing some issues, please try again later. Our team is working diligently to resolve the issue. Thank you for your patience and ...
mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved product Company expects supply to be available ... · ACCESS Newswire · Moderna, Inc. The above button links to ...
CAMBRIDGE, May 23, 2025 (Newswire.com) - Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results